Gastrointestinal oncology
Clinical research focuses on solid neoplasms of the digestive system, including colorectal cancer, gastric cancer, and tumors of the hepato-bilio-pancreatic and neuroendocrine districts.
- Primary and metastatic digestive tumors
- Curative surgical resection
- Oncologic disease localization
The sponsor’s activity in this area is centered on surgical oncology for tumors considered suitable for resection with curative intent.
Fluorescence-guided surgery
Research interest includes in-vivo visualization of neoplastic tissue and tumor margins during surgical oncology procedures using fluorescence imaging.
- Intraoperative tumor detection
- Margin assessment
- Image-guided resection
This area reflects a focus on improving surgical precision in the management of gastrointestinal malignancies.
Indocyanine green imaging
The trial landscape includes the use of indocyanine green (ICG) as a fluorescent tracer for enhancing the visibility of tumor tissue during operative procedures.
- ICG-based visualization
- Intraoperative fluorescence
- Tumor boundary delineation
Interest is directed toward diagnostic support within the operating room rather than systemic cancer treatment.
Extracellular vesicle-based delivery
Research activity also involves autologous extracellular vesicles (EVs) as a delivery platform for directing imaging agents to neoplastic tissue.
- Autologous EVs
- Targeted tissue delivery
- Molecular imaging support
This domain links nanomedicine and oncologic imaging in the context of surgical diagnosis.
